http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : 조세헌 (검색결과 74 건)
- 무료
- 기관 내 무료
- 유료
-
Substance P에 의한 가토 회장평활근의 수축기전에 대한 연구
조세헌,정진섭,이상호,Jo, Se-Hun,Jung, Jin-Sup,Lee, Sang-Ho 대한생리학회 1984 대한생리학회지 Vol.18 No.2
가토의 회장평활근에서 substance P의 수축기전을 밝히기 위하여 본 실험을 시행하여 다음과 같이 요약하였다. 1) SP는 $10^{-9}M$부터 수축을 일으켜 $10^{-7}M$에서 최대수축을 나타내었고 그 생도는 $10^{-6}M$ acetylcholine에 의한 수축의 90%에 달하였다. 2) SP를 농도별로 부가적으로 투여할 때는 SP를 각 농도마다 따로 투여함 때보다 수축의 크기가 크게 감소하였다. 3) $10^{-7}M$ SP로 5분간 처리한 회장평활근의 $10^{-8}M$ SP에 글한 반응은 $10^{-7}M$과 $10^{-8}M$ SP 투여시간의 간격이 클수록 증가하여 20분후 정상으로 회복되었다. 4) $10^{-7}M$ SP로 3분 처리후에도 $10^{-6}M$ acetylcholine에 의한 수축은 영향을 받지 않았다. 5) $10^{-7}M$ SP에 의한 수축은 $10^{-6}M$ atropine에 의해 영향을 받지 않았고 3mM TEA전처치시 $10^{-7}M$ SP에 의한 수축은 정상이거나 약간 감소하였고 SP 전처치시 TEA 수축은 감소하였다. 6) $10^{-8}M$ SP와 3mM TEA에 의한 수축은 Na없는 용액, $10^{-4}M$ ouabain, 100k용액에 의해 완전히 억제되었고 $10^{-6}M$ NE 존재시는 40% 정도 억제되었다. $10^{-7}M$ SP에 의한 수축은 각 조건내서 완전히 억제되지 않았다. K없는 용액에서 $10^{-8}M$ SP 의한 수축은 완전히 억제되고 $10^{-7}M$ SP와 TEA에 의한 수축은 완전히 억제되지 않았다. 7) SP에 의한 수축은 0. 1 mM $Ca^{2+}$존재시 상당히 억제되었고 외부 $Ca^{2+}$증가시 증가하여 1.8 mM $Ca^{2+}$에서 최고에 달하였으며 그 이후는 오히려 감소하였다. SP수축의 감소속도는 0.5mM $Ca^{2+}$에 의해 증가하였으나 1.8mM이상의 $Ca^{2+}$농도에서는 영향을 받지 않았다. 8) $Ca^{2+}$없는 용액에서 $10^{-7}M$ SP는 수축을 일으켰고 그 수축의 크기는 $Ca^{2+}$없는 용액으로 처리시간이 증가함에 따라 감소하며 10분후 완전 소실되었다. 9) $Ca^{2+}$없는 용액으로 처리시간이 길어질수록 0.5mM $Ca^{2+}$에서 $10^{-7}M$ SP에 의한 수축은 감소하였다. 10) $Ca^{2+}$없는 용액에서 10분간 처리한 후 $10^{-7}M$ SP에 의한 수축은 Ca loading time이 길수록 외부 $Ca^{2+}$농도가 높을수록 증가하였다. 이상의 결과로 볼 때 저농도의 SP는 주로 외부 $Ca^{2+}$의 유입에 의해 수축을 일으키는 것으로 생각되며 이 $Ca^{2+}$의 유입에 관여하는 기전은 $K^+$투과도의 감소에 의한 막전위의 탈분극만으로 완전히 설명할 수 없었고 고농도의 SP에 의한 수축에는 세포내부 $Ca^{2+}$의 유리도 관여하고 이 $Ca^{2+}$저장고는 세포막과 밀접하게 연결되어 있는 것으로 생각된다. The mechanism of the contractile response of longitudial muscle of rabbit ileum to substance P (SP) has been investigated. The contractions in rabbit ileum under various conditions were recorded isometrically The following results were obtained. 1) The contractions by SP increased according to concentrations. SP·induced contraction was not sustained but faded rapidly at $10^{-7}M$. The response to the commutative addition of SP was decreased in comparison to the response to separate administration of each concentration . 2) The response to $10^{-8}M$ SP after 5 min application cf $10^{-7}M$ SP was increased with increasing the time interval between the administration of $10^{-7}$ and $10^{-8}M$ SP. 3) The treatment of rabbit ileum by $10^{-7}M$ SP for 5 min didn't decrease the response to $10^{-6}M$ acetylcholine. 4) $10^{-6}M$ atropine had no effect of the contractile response to $10^{-7}M$ SP. The response to $10^{-7}M$ SP was normal or subnormal in the presence of 3 mM tetraethylammonium(TEA). 5) 100k solution, $10^{-4}M$ ouabain, and Na-free solution inhibited the response to $10^{-8}M$ SP and 3 mM TEA completely, and to $10^{-7}M$ SP incompletely. 3 mM TEA induced a considerable contraction in K-free solution, but $10^{-8}M$ SP didn't induce the contraction. $10^{-6}M$ norepinephrine decreased the contractile responses to SP and TEA. 6) The contractile response to $10^{-7}M$ SP was dependent on the extracellular $Ca^{2+}$ concentrations to 1.8 mM. 7) The contractile response to $10^{-7}M$ SP remained 15% of the maximal response after bathing the ileum in a Ca-free solution for 2.5 min. 8) The responsiveness to SP was completely lost within 10 min of bathing in Ca-free solution, but was restored by the exposure to $Ca^{2+}$. The restorative effect of $Ca^{2+}$ depended on the concentration of $Ca^{2+}$, and on time for which the tissue exposed to this $Ca^{2+}$ concentration. These results suggest that there are two mechanisms of the action by which the low concentrations of substance P causes the contraction of intestinal smooth muscle: the reduction of K conductance and a mechanism dependent on the extracellular $Ca^{2+}$, and that high concentration of SP may elicit a contraction by releasing $Ca^{2+}$ from an intracellular store, which is not as sensitive to removal of extracellular $Ca^{2+}$ or as easily accessible to EGTA as the extracellular space of the muscle. The location of this store is not known; it may be associated with the internal side of the cell membrane.
-
-
Use of Antidepressants in Patients with Breast Cancer Taking Tamoxifen
조세헌,김성환,이미리,이근철,이진화,권혁찬,김대철,이경우 한국유방암학회 2010 Journal of breast cancer Vol.13 No.4
Tamoxifen, a selective estrogen modulator has been used for more than three decades to treat all stages of estrogen receptor (ER)-positive breast cancer and to prevent the disease. Tamoxifen is a pro-drug that requires metabolic activation to 4-hydroxytamoxifen and 4-hydroxy-N-desmethyltamoxifen (endoxifen) to elicit its pharmacological activity. Endoxifen has identical properties and potency with 4-hydroxytamoxifen, but is present in concentrations up to 10-fold higher than 4-hydroxytamoxifen. The cytochrome P450 2D6 (CYP2D6) enzyme plays a key role in converting tamoxifen into its active metabolites with significantly greater affinity for the ER and greater ability to inhibit cell proliferation. Genetic variants in the CYP2D6 gene may result in CYP2D6 enzymes with reduced or null activity, thereby decreasing the anti-cancer effect. In addition to genetic inactivation of CYP2D6, inhibitors of CYP2D6, including some antidepressants to treat hot flashes or depression in patients with breast cancer, may also alter enzyme activity and negatively affect the outcomes of patients receiving adjuvant tamoxifen. This article reviews and discusses the following issues: tamoxifen metabolism, antiproliferative effects of tamoxifen and its metabolites, CYP2D6 genetic polymorphisms, treatment for hot flashes and depression in breast cancer, and the pharmacological interactions between tamoxifen and antidepressants via CYP2D6. Although routine CYP2D6 testing is not recommended yet, coadministration of potent or intermediate CYP2D6 inhibitors in women taking tamoxifen should be avoided.
-
-
-
-
-
-
유방암종에서 p27kip1 단백의 세포 내 발현 위치와 예후와의 관련성
홍숙희,김대철,조세헌,홍영습 대한병리학회 2006 Journal of Pathology and Translational Medicine Vol.40 No.3
Background : p27 is a member of the cyclin-dependent kinase (CDK)inhibitors that arrest the progression of the cell cycle; thus, it acts as a tumor suppressor gene. The loss or decrease of p27 protein is frequently seen and this has an independent prognostic potential for many human cancers. p27 is functionally inactivated through accelerated proteolysis and cytoplasmic sequestration. Cytoplasmic mislocalization of p27 by abnormal phosphorylation in the tumor cells doesn’t allow it to bind and inhibit nuclear cyclin/CDK targets. Methods : We examined the p27 protein expression in 86 cases of invasive ductal carcinoma of the breast via immunohistochemical staining to evaluate the subcellular localization of p27 and its relationship with the clinicopathologic features and the prognostic factors. Results : The nuclear expression of p27 was noted in 48.9% of the tumors, a combined nuclear and cytoplasmic expression was noted in 20.9%, a cytoplasmic expression was noted in 12.8%, and a negative expression was noted in 17.4%. The decreased nuclear expression and/or cytoplasmic mislocalization of p27 were statistically correlated with the nuclear grade (p=0.001), histologic grade (p=0.036), tumor size (p=0.033), lymph node metastasis (p=0.043), ER (p=0.001), and PR (p=0.001) status, while they were not correlated with patient age, stage, HER2, p53, and Ki67. Conclusions : The breast tumors showing both decreased nuclear expression and cytoplasmic mislocalization of p27 are associated with a deranged cell cycle via functional inactivation and also with poor prognostic factors. It is expected that p27 can be a promising anticancer target molecule for the treatment of breast cancer.
-
ScienceON
스콜라연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
